GC-MS SCRUTINY OF PHYTOCONSTITUENTS, IN VITRO EVALUATION OF ANTIHYPERGLYCEMIC, ANTIADIPOGENIC ACTIVITIES, AND CYTOTOXIC EFFECT USING 3T3 L1 ADIPOCYTE CELL LINE AND MOLECULAR DOCKING STUDIES OF PREMNA CORYMBOSA

Objective: The present study was intended to list out the phytochemical multiples and to investigate the antihyperglycemic effect of Premna corymbosa using in vitro assays and in silico molecular docking methods. Methods: The phytochemical multiples of methanol proportion of P. corymbosa leaves were...

Full description

Saved in:
Bibliographic Details
Published inAsian journal of pharmaceutical and clinical research pp. 106 - 116
Main Authors RADHIKA S, SENTHILKUMAR R
Format Journal Article
LanguageEnglish
Published 07.10.2024
Online AccessGet full text

Cover

Loading…
Abstract Objective: The present study was intended to list out the phytochemical multiples and to investigate the antihyperglycemic effect of Premna corymbosa using in vitro assays and in silico molecular docking methods. Methods: The phytochemical multiples of methanol proportion of P. corymbosa leaves were appraised by Gas Chromatography-Mass Spectrometry (GC-MS) scrutiny to illustrate the attendance of phytochemical composites. Moreover, the in vitro antihyperglycemic, antiadipogenic activities, and cytotoxic effects of the extract were elucidated using a 3T3 L1 adipocyte cell line. Mode of action of phytochemical composites in methanol leaf extract of P. corymbosa was probed by Western blotting with IRS1, IRS2, mTOR, and glucose transporter type 4 (GLUT 4) receptors. At present, to probe the consequence of the aboriginal drugs, it is necessary to perform in silico docking on the diabetic receptor which could be useful for the progress of enhanced formulation for the psychoanalysis of diabetes. Results: The GC-MS scrutiny depicted the being there of thirty-five phytochemical multipart. Amid the thirty-five multipart’s recognized, focal composites were Phytol, acetate (RT-16.78), n-Hexadecanoic acid (RT-18.16), Phytol (RT-19.51), 9,12,15-octadecatrienoic acid (Z,Z,Z) (RT-19.85), octadecanoic acid (RT-20.04), and Bis (2-ethylhexyl) phthalate (RT-23.09). The results of the glucose conception assay, adipocyte differentiation assay, and MTT assay showed potent in vitro antihyperglycemic activity with methanol leaf extract of P. corymbosa in 3T3l1Cell line. The results attained from western blotting revealed good antihyperglycemic activity of P. corymbosa. The in silico molecular docking results illustrated that the selected herbal lead compound is an effective target against the receptors. The compound showed favorable interactions with the amino acid residues thereby substantiating their proven efficacy as an antihyperglycemic compound. Conclusion: The outcome of the current study substantiates the antihyperglycemic prospective of the methanol leaf extract of P. corymbosa on the hyperglycemic causal agents and its activity against diabetes by a molecular approach.
AbstractList Objective: The present study was intended to list out the phytochemical multiples and to investigate the antihyperglycemic effect of Premna corymbosa using in vitro assays and in silico molecular docking methods. Methods: The phytochemical multiples of methanol proportion of P. corymbosa leaves were appraised by Gas Chromatography-Mass Spectrometry (GC-MS) scrutiny to illustrate the attendance of phytochemical composites. Moreover, the in vitro antihyperglycemic, antiadipogenic activities, and cytotoxic effects of the extract were elucidated using a 3T3 L1 adipocyte cell line. Mode of action of phytochemical composites in methanol leaf extract of P. corymbosa was probed by Western blotting with IRS1, IRS2, mTOR, and glucose transporter type 4 (GLUT 4) receptors. At present, to probe the consequence of the aboriginal drugs, it is necessary to perform in silico docking on the diabetic receptor which could be useful for the progress of enhanced formulation for the psychoanalysis of diabetes. Results: The GC-MS scrutiny depicted the being there of thirty-five phytochemical multipart. Amid the thirty-five multipart’s recognized, focal composites were Phytol, acetate (RT-16.78), n-Hexadecanoic acid (RT-18.16), Phytol (RT-19.51), 9,12,15-octadecatrienoic acid (Z,Z,Z) (RT-19.85), octadecanoic acid (RT-20.04), and Bis (2-ethylhexyl) phthalate (RT-23.09). The results of the glucose conception assay, adipocyte differentiation assay, and MTT assay showed potent in vitro antihyperglycemic activity with methanol leaf extract of P. corymbosa in 3T3l1Cell line. The results attained from western blotting revealed good antihyperglycemic activity of P. corymbosa. The in silico molecular docking results illustrated that the selected herbal lead compound is an effective target against the receptors. The compound showed favorable interactions with the amino acid residues thereby substantiating their proven efficacy as an antihyperglycemic compound. Conclusion: The outcome of the current study substantiates the antihyperglycemic prospective of the methanol leaf extract of P. corymbosa on the hyperglycemic causal agents and its activity against diabetes by a molecular approach.
Author SENTHILKUMAR R
RADHIKA S
Author_xml – sequence: 1
  surname: RADHIKA S
  fullname: RADHIKA S
– sequence: 2
  surname: SENTHILKUMAR R
  fullname: SENTHILKUMAR R
BookMark eNpNUVtKxDAUDaKgjq7BLGCqebRN-xkzmU4wTYY2FftVOukUFF-0ILhMd2SnCnp_7uW8uHDOwfHr2-segCuMrgnBUXrTPr374ZogEn5g9jjBEU6T-AicoZSFAQlDfPzvPgWX4_iEpqFpxDA7A1-ZCPISlqKonDI1tGu43dTOCmtKp1wljSuXUBl4r1xhobznuuJOWXNQcuPUpt7KItO1kLkSyxniK7W1mTRKQC6cmpxKlgdqBcUU7ezDxMj1WgoHq1KZDFJHocZwNk4SCYXUGmpl5OzKrZai0ryAKyvuDobSVaspdH63kLnhUNiizm9tyS_ASd8-j_vL370A1Vo6sQm0zZTgOvA4ZnHQRb2PGU7bmFIUM4J6kqQt81GXsCTG3Q4lHfWd7zHd4bgLk9B7jxFqW5wQQvd0AdhPrh_exnHY98378PjSDp8NRs1cTjOX0_yV08zl0G9VhHb_
Cites_doi 10.21203/rs.3.rs-319858/v1
10.1002/ptr.7205
10.1016/S0005-2760(98)00133-7
10.1046/j.1432-1327.1999.00809.x
10.1002/mnfr.200900460
10.1677/JOE-09-0037
10.4172/2155-9872.1000356
10.1039/C0MB00089B
10.4172/jpb.1000140
10.1093/emboj/16.24.7432
10.1101/gad.5.9.1538
10.1074/jbc.M808282200
10.3390/ijms22094648
10.1091/mbc.e05-10-0969
10.1016/0006-3002(63)90513-4
10.1016/j.ejmech.2011.10.007
10.3390/ijms20235898
10.1016/S1097-2765(00)80210-5
10.9734/irjpac/2021/v22i330396
10.1016/j.mce.2012.01.024
10.4103/0974-8490.122919
10.4018/978-1-5225-0362-0.ch011
10.1016/S1097-2765(00)80211-7
10.1155/2018/4170372
10.1074/jbc.M707775200
10.1007/s00424-020-02417-x
10.1074/jbc.M200958200
10.3923/rjphyto.2014.42.46
10.2174/138620712799361825
10.1124/jpet.102.033553
10.9734/EJMP/2014/7618
10.1016/S0021-9258(18)47623-5
10.1038/nm.2307
10.3923/rjphyto.2011.163.169
10.2202/1553-3840.1151
10.1074/jbc.M004046200
10.1021/acsomega.0c01323
10.1016/S2222-1808(12)60144-3
10.4103/0973-8258.126826
10.1006/abio.1976.9999
10.1093/carcin/19.2.287
10.1016/S1097-2765(00)80306-8
10.1074/jbc.275.3.1873
10.1128/MCB.16.8.4128
10.1016/S1097-2765(00)80209-9
10.9790/3008-09412630
10.1074/jbc.273.44.28945
10.1016/S0140-6736(11)60679-X
ContentType Journal Article
DBID AAYXX
CITATION
DOI 10.22159/ajpcr.2024v17i10.51986
DatabaseName CrossRef
DatabaseTitle CrossRef
DatabaseTitleList CrossRef
DeliveryMethod fulltext_linktorsrc
Discipline Pharmacy, Therapeutics, & Pharmacology
EISSN 0974-2441
EndPage 116
ExternalDocumentID 10_22159_ajpcr_2024v17i10_51986
GroupedDBID ---
23N
2WC
53G
5VS
AAYXX
ADBBV
ALMA_UNASSIGNED_HOLDINGS
BAWUL
CITATION
DIK
E3Z
GX1
HH5
KQ8
M~E
OK1
RNS
TR2
ID FETCH-LOGICAL-c1676-d5fc6719a63306720f289a7c5d87861db08d3cdcf13b16d484ccc100aa18223e3
ISSN 0974-2441
IngestDate Tue Jul 01 00:08:32 EDT 2025
IsDoiOpenAccess false
IsOpenAccess true
IsPeerReviewed false
IsScholarly true
Language English
License http://creativecommons.org/licenses/by/4.0
LinkModel OpenURL
MergedId FETCHMERGED-LOGICAL-c1676-d5fc6719a63306720f289a7c5d87861db08d3cdcf13b16d484ccc100aa18223e3
OpenAccessLink https://journals.innovareacademics.in/index.php/ajpcr/article/download/51986/30921
PageCount 11
ParticipantIDs crossref_primary_10_22159_ajpcr_2024v17i10_51986
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2024-10-07
PublicationDateYYYYMMDD 2024-10-07
PublicationDate_xml – month: 10
  year: 2024
  text: 2024-10-07
  day: 07
PublicationDecade 2020
PublicationTitle Asian journal of pharmaceutical and clinical research
PublicationYear 2024
References 1254780
1254743
1254787
1254744
1254788
1254741
1254785
1254742
1254786
1254783
1254740
1254784
1254781
1254782
1254749
1254747
1254748
1254745
1254789
1254746
1254776
1254733
1254777
1254774
1254775
1254772
1254773
1254770
1254771
1254738
1254739
1254736
1254737
1254734
1254778
1254735
1254779
1254765
1254766
1254763
1254764
1254761
1254762
1254760
1254769
1254767
1254768
1254790
1254791
1254754
1254755
1254752
1254796
1254753
1254750
1254794
1254751
1254795
1254792
1254793
1254758
1254759
1254756
1254757
References_xml – ident: 1254756
  doi: 10.21203/rs.3.rs-319858/v1
– ident: 1254742
  doi: 10.1002/ptr.7205
– ident: 1254744
  doi: 10.1016/S0005-2760(98)00133-7
– ident: 1254784
  doi: 10.1046/j.1432-1327.1999.00809.x
– ident: 1254741
– ident: 1254776
  doi: 10.1002/mnfr.200900460
– ident: 1254746
  doi: 10.1677/JOE-09-0037
– ident: 1254758
– ident: 1254754
  doi: 10.4172/2155-9872.1000356
– ident: 1254770
– ident: 1254774
– ident: 1254739
– ident: 1254777
– ident: 1254763
  doi: 10.1039/C0MB00089B
– ident: 1254796
  doi: 10.4172/jpb.1000140
– ident: 1254789
  doi: 10.1093/emboj/16.24.7432
– ident: 1254793
  doi: 10.1101/gad.5.9.1538
– ident: 1254749
  doi: 10.1074/jbc.M808282200
– ident: 1254745
  doi: 10.3390/ijms22094648
– ident: 1254766
  doi: 10.1091/mbc.e05-10-0969
– ident: 1254764
  doi: 10.1016/0006-3002(63)90513-4
– ident: 1254778
  doi: 10.1016/j.ejmech.2011.10.007
– ident: 1254747
  doi: 10.3390/ijms20235898
– ident: 1254787
  doi: 10.1016/S1097-2765(00)80210-5
– ident: 1254775
– ident: 1254757
– ident: 1254755
  doi: 10.9734/irjpac/2021/v22i330396
– ident: 1254748
  doi: 10.1016/j.mce.2012.01.024
– ident: 1254760
  doi: 10.4103/0974-8490.122919
– ident: 1254752
  doi: 10.4018/978-1-5225-0362-0.ch011
– ident: 1254788
  doi: 10.1016/S1097-2765(00)80211-7
– ident: 1254743
  doi: 10.1155/2018/4170372
– ident: 1254762
  doi: 10.1074/jbc.M707775200
– ident: 1254750
  doi: 10.1007/s00424-020-02417-x
– ident: 1254783
  doi: 10.1074/jbc.M200958200
– ident: 1254736
  doi: 10.3923/rjphyto.2014.42.46
– ident: 1254795
– ident: 1254772
– ident: 1254753
  doi: 10.2174/138620712799361825
– ident: 1254768
  doi: 10.1124/jpet.102.033553
– ident: 1254737
  doi: 10.9734/EJMP/2014/7618
– ident: 1254761
  doi: 10.1016/S0021-9258(18)47623-5
– ident: 1254790
  doi: 10.1038/nm.2307
– ident: 1254740
  doi: 10.3923/rjphyto.2011.163.169
– ident: 1254769
– ident: 1254781
  doi: 10.2202/1553-3840.1151
– ident: 1254792
  doi: 10.1074/jbc.M004046200
– ident: 1254782
– ident: 1254751
  doi: 10.1021/acsomega.0c01323
– ident: 1254780
  doi: 10.1016/S2222-1808(12)60144-3
– ident: 1254735
  doi: 10.4103/0973-8258.126826
– ident: 1254767
  doi: 10.1006/abio.1976.9999
– ident: 1254734
– ident: 1254771
  doi: 10.1093/carcin/19.2.287
– ident: 1254759
– ident: 1254738
– ident: 1254791
  doi: 10.1016/S1097-2765(00)80306-8
– ident: 1254773
– ident: 1254765
  doi: 10.1074/jbc.275.3.1873
– ident: 1254794
  doi: 10.1128/MCB.16.8.4128
– ident: 1254786
  doi: 10.1016/S1097-2765(00)80209-9
– ident: 1254779
  doi: 10.9790/3008-09412630
– ident: 1254785
  doi: 10.1074/jbc.273.44.28945
– ident: 1254733
  doi: 10.1016/S0140-6736(11)60679-X
SSID ssj0000395717
Score 2.3175774
Snippet Objective: The present study was intended to list out the phytochemical multiples and to investigate the antihyperglycemic effect of Premna corymbosa using in...
SourceID crossref
SourceType Index Database
StartPage 106
Title GC-MS SCRUTINY OF PHYTOCONSTITUENTS, IN VITRO EVALUATION OF ANTIHYPERGLYCEMIC, ANTIADIPOGENIC ACTIVITIES, AND CYTOTOXIC EFFECT USING 3T3 L1 ADIPOCYTE CELL LINE AND MOLECULAR DOCKING STUDIES OF PREMNA CORYMBOSA
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnZ1Lj9MwEICtsly4IJ7iLR_QXtJAnDivY0izTWgeVeqs2lOVVwUcSgVdpOVf8g_4KYydNMnuVoLlElV-1e18tWemnjFCb3XTLgpdq2XYHiyZkg2RYQ0EK4XaBTc_aGHz4OQoNvyMflzqy9Ho9-DU0sW-eFf-PBpX8j9ShTKQK4-SvYVku0GhAF6DfOEJEobnP8l46soRvzEjzVgQr_gBnrm_YombxAsWsMyL2aIJSJLOA5YmknfuhFlzzw60dWIW-Cue1iRcuVwcYp2AQmcSzJOpFwc8MyMLoC_ojE3lRHLhDViyhDpQcT2XSfzijqmkMU0KiSS6QhNPcrlHLAxiT_SKktBzs9BJpUnizniHVhUVk069KHa4z2wVfUgWzlBhdkSQ5yC_xe7TFSe8CMs7RHe2mYs6D3fqTPxg5vTu3QV8JX4QzrIIZpIOPR4qFWfnzKHr0qQyqCUNk_WRsmYxJoox2NdJE9N5fctQQefhKVfzL7uS54dV6Q9ifoYKUG2PJem-tnl2RxrBmBJDrcVA636gtRjoDrqrgiHD79iYLknnBVT436TiWujuAzSHEMVY749PaqBCDXQh9gDdb40Y7DREPkSjevsInc4byVyOMeuD-r6P8Sme9_nRLx-jXwJbfMAWJ2f4BrZjHMRYQIt7aHnLG9CO8VVkcY8sr5rgDljcAIsFsBiAxSHBHbCYA4s5sKJXByxugcUtsGK6AljcAfsEZWcec325vVlELolhGnKlb0rDJHZuaNxkVpWNatm5WeqVZVoGqQrFqrSyKjdEK4hRUYuWZUkUJc_BHFe1WnuKTrZft_UzhDe5ZdFar2q7yGGRM3Oa53qu1TbVKr1WiudIOQhrvWsSyKz_wsqL23d5ie71v5RX6GT_7aJ-DdryvngjgPsD11qdwg
linkProvider Geneva Foundation for Medical Education and Research
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=GC-MS+SCRUTINY+OF+PHYTOCONSTITUENTS%2C+IN+VITRO+EVALUATION+OF+ANTIHYPERGLYCEMIC%2C+ANTIADIPOGENIC+ACTIVITIES%2C+AND+CYTOTOXIC+EFFECT+USING+3T3+L1+ADIPOCYTE+CELL+LINE+AND+MOLECULAR+DOCKING+STUDIES+OF+PREMNA+CORYMBOSA&rft.jtitle=Asian+journal+of+pharmaceutical+and+clinical+research&rft.au=RADHIKA+S&rft.au=SENTHILKUMAR+R&rft.date=2024-10-07&rft.issn=0974-2441&rft.eissn=0974-2441&rft.spage=106&rft.epage=116&rft_id=info:doi/10.22159%2Fajpcr.2024v17i10.51986&rft.externalDBID=n%2Fa&rft.externalDocID=10_22159_ajpcr_2024v17i10_51986
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0974-2441&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0974-2441&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0974-2441&client=summon